X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Go back to X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
(NASDAQ: XFOR) Delayed: 3.50 --0 (-0%)
Previous Close $3.50    52 Week High
Open $3.50    52 Week Low
Day High $3.50    P/E N/A 
Day Low $3.50    EPS
Volume 138